.harvard medical school: "cgrp: a new era for migraine treatment."...but what if it had happened in one of the maine schools where the rate is 10 percent or more?.. march 2017 (21).following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).